ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,722.26
      -0.19%
      US Tech 100
      19,518.00
      0.53%
      Dow Jones
      41,914.75
      -0.70%
      Brent Oil
      71.245
      -2.66%
      Bitcoin
      63,720.39
      0.93%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Alkido Pharma Inc (AIKI) Quote

      Alkido Pharma Inc

      Alkido Pharma Inc (AIKI)

      NASDAQ
      3.56
      0.00
      (0.00%)
      Closed September 26 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      3.56
      Bid
      3.53
      Ask
      3.98
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      19.028M
      Previous Close
      3.56
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      5,345,000
      Dividend Yield
      -
      PE Ratio
      -0.38
      Earnings Per Share (EPS)
      -4.28
      Revenue
      2.04M
      Net Profit
      -22.88M

      About Alkido Pharma Inc

      AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin... AIkido Pharma Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing a antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Show more

      Sector
      Security Brokers & Dealers
      Industry
      Security Brokers & Dealers
      Website
      www.dominariholdings.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -

      Ask ADVFN Intelligence (AI)

      AIKI Latest News

      More News

      Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown"

      Dominari Securities CEO, Kyle Wool, Discusses the IPO Market on "The Claman Countdown" PR Newswire NEW YORK, June 21, 2023 NEW YORK, June 21, 2023 /PRNewswire/ -- Dominari Holdings Inc...

      June 21 2023
      PR Newswire (US)

      Dominari Holdings Appoints George Way Chief Financial Officer

      Dominari Holdings Appoints George Way Chief Financial Officer PR Newswire NEW YORK, April 3, 2023 Experienced Finance Executive to Support Growth Strategy  NEW YORK, April 3, 2023 /PRNewswire/...

      April 03 2023
      PR Newswire (US)

      Dominari Holdings Provides Update on Share Repurchase Program

      Dominari Holdings Provides Update on Share Repurchase Program PR Newswire NEW YORK, Feb. 24, 2023 NEW YORK, Feb. 24, 2023 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the...

      February 24 2023
      PR Newswire (US)

      Dominari Holdings Provides Update on Share Repurchase Program

      Dominari Holdings Provides Update on Share Repurchase Program PR Newswire NEW YORK, Dec. 28, 2022 NEW YORK, Dec. 28, 2022 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the...

      December 28 2022
      PR Newswire (US)

      AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH)

      AIkido Pharma Announces Name and Stocker Ticker Symbol Change to Dominari Holdings Inc. (Nasdaq: DOMH) PR Newswire NEW YORK, Dec. 22, 2022 NEW YORK, Dec. 22, 2022 /PRNewswire/ -- AIkido Pharma...

      December 22 2022
      PR Newswire (US)

      AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes

      AIkido Pharma Announces Successful Initial Public Offering of ASP Isotopes PR Newswire NEW YORK, Nov. 28, 2022 Leading Advanced Materials Company Now Listed on NASDAQ under the symbol, ASPI NEW...

      November 28 2022
      PR Newswire (US)

      AIkido Share Repurchase Continues

      AIkido Share Repurchase Continues PR Newswire NEW YORK, Oct. 6, 2022 NEW YORK, Oct. 6, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update...

      October 06 2022
      PR Newswire (US)

      AIkido Purchases More Shares

      AIkido Purchases More Shares PR Newswire NEW YORK, Oct. 5, 2022 NEW YORK, Oct. 5, 2022 /PRNewswire/ -- AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company") today provided an update on...

      October 05 2022
      PR Newswire (US)

      Share Repurchase Program Continues

      Share Repurchase Program Continues PR Newswire NEW YORK, Oct. 4, 2022 NEW YORK, Oct. 4, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update...

      October 04 2022
      PR Newswire (US)

      AIkido Pharma Continues Share Repurchase Program

      AIkido Pharma Continues Share Repurchase Program PR Newswire NEW YORK, Oct. 3, 2022 NEW YORK, Oct. 3, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today...

      October 03 2022
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      RZLVRezolve AI Ltd
      $ 7.44
      (51.22%)
      		3.17M
      RNAZTransCode Therapeutics Inc
      $ 0.63
      (51.12%)
      		12.73M
      ATGLAlpha Technology Group Limited
      $ 2.16
      (49.72%)
      		3.42M
      INVZWInnoviz Technologies Ltd
      $ 0.18
      (45.69%)
      		11.02k
      OCTOEightco Holdings Inc
      $ 3.61
      (44.98%)
      		100.6M
      VTNRVertex Energy Inc
      $ 0.1501
      (-58.42%)
      		49.72M
      CMCTCreative Media and Community Trust Corporation
      $ 0.71
      (-54.63%)
      		3.56M
      SFIXStitch Fix Inc
      $ 2.28
      (-39.20%)
      		23.88M
      SHOTWSafety Shot Inc
      $ 0.22
      (-31.25%)
      		11.82k
      ARQQArqit Quantum Inc
      $ 4.40
      (-29.63%)
      		438.63k
      NVDANVIDIA Corporation
      $ 123.51
      (2.18%)
      		284.49M
      MLGOMicroAlgo Inc
      $ 0.2744
      (26.92%)
      		142.29M
      SQQQProShares UltraPro Short QQQ
      $ 7.47
      (-2.35%)
      		124.15M
      CEROCERo Therapeutics Holdings Inc
      $ 0.0986
      (5.23%)
      		123.59M
      INTCIntel Corporation
      $ 23.54
      (3.20%)
      		117.01M

      AIKI Discussion

      View Posts
      Viewmont Viewmont 2 years ago
      Got it thanks!
      👍️0
      Viewmont Viewmont 2 years ago
      Hi, I haven't been following AIKI for a while, just noticed its not trading, checked TDA / google with no result, did the ticker change or not public anymore after company bought shares? Thanks!
      👍️0
      db101 db101 2 years ago
      More insider shares purchased today…
      👍️0
      db101 db101 2 years ago
      More insider shares purchased…
      👍️0
      db101 db101 2 years ago
      AIKI looks to be headed back to 7…
      👍️0
      db101 db101 2 years ago
      More insider shares purchased…
      👍️0
      db101 db101 2 years ago
      A positive week… up 3.11%
      👍️0
      db101 db101 2 years ago
      …more shares purchased by the CEO
      👍️0
      db101 db101 2 years ago
      …AIKI seems to be getting its legs
      👍️0
      db101 db101 2 years ago
      AIKI is undervalued…
      👍️0
      db101 db101 2 years ago
      AIKI is ready…
      👍️0
      db101 db101 2 years ago
      The Company reported that on October 5, 2022, the Company purchased 10,500 shares of common stock at $7.0679 per share.
      👍️0
      db101 db101 2 years ago
      The Company reported that on October 4, 2022, the Company purchased 38,035 shares of common stock at $6.99 per share. Anthony Hayes, CEO of AIkido stated, "We believe the Company stock continues to be undervalued and we are using this opportunity to enhance shareholder value by reducing the amount of stock that is outstanding."
      👍️0
      db101 db101 2 years ago
      AIKI is buying more shares… 45k
      👍️0
      ANTI-BAGHOLDER ANTI-BAGHOLDER 2 years ago
      Shalom Auerbach board member on AMRR doesn’t mess around.



      Shalom Auerbach, a significant stockholder of AIkido Pharma Inc. (NASDAQ: AIKI) beneficially owning approximately 3.4% of its common stock, today issued the following letter to members of the AIkido Pharma Inc. Board of Directors:

      https://www.streetinsider.com/dr/news.php?id=20187179&gfv=1
      👍️0
      PStockPickz PStockPickz 3 years ago
      https://www.prnewswire.com/news-releases/aikido-pharma-secures-interest-in-electric-truck-maker-tevva-motors-ltd-301386841.html
      👍️0
      PStockPickz PStockPickz 3 years ago
      Averaging in some .48s
      👍️0
      PStockPickz PStockPickz 3 years ago
      Snagging some 50s
      👍️0
      RNsidersbuying RNsidersbuying 3 years ago
      AIkido Pharma announces $3M share repurchase program

      https://ih.advfn.com/stock-market/NASDAQ/alkido-pharma-AIKI/stock-news/87087386/aikido-pharma-announces-3m-share-repurchase-progr
      👍️0
      urge2surge urge2surge 3 years ago
      Classic dog pile here. I'm out and won't be back.
      👍️0
      RNsidersbuying RNsidersbuying 3 years ago
      AIKI .47 - So, outsiders have sold this company's stock down to less than .50-on-the-dollar and insiders aren't filing Form-4-Buys by the truckload? How can management EVER promote it's own stock again when they show no interest in less than .50-on-the-dollar?

      And what would be management's risk be in buying here at less than .50-on-the-dollar? It goes down to .25-on-the-dollar...whoa-is-me
      👍️0
      urge2surge urge2surge 3 years ago
      One of the worst companies I've invested in. Finally dumped it for big loss. I obviously played the fool again. Glta
      👍️0
      georgie18 georgie18 3 years ago
      AIKI...72...:partying_face:
      👍️0
      db101 db101 3 years ago
      Get ready for the buttered popcorn...
      👍️0
      georgie18 georgie18 3 years ago
      AIKI...73...Bullish 3 Gap Downs Reversal Pattern to the Upside on this Oversold Chart...

      Psar flipped Bullish...Been accumulating under $1...

      Chart https://schrts.co/exhPMSRA ...
      👍️0
      White Lightning White Lightning 3 years ago
      Looks like good news AlKl

      https://apple.news/AnumIdrGsR-CRYxMFTxj-5Q

      This should go over a dollar soon here!!!!
      👍️0
      TheFinalCD TheFinalCD 3 years ago
      AIkido owns 525,000 shares of DatChat, which it previously purchased for $500,000.00. As of September 13th, DatChat shares closed at $6.54, well higher than its IPO price and representing a more than 600% return or an additional $3,433,500.00 added to AIKI balance sheet. $AIKI

      AIkido owns 525,000 shares of DatChat, which it previously purchased for $500,000.00. As of September 13th, DatChat shares closed at $6.54, well higher than its IPO price and representing a more than 600% return or an additional $3,433,500.00 added to AIKI balance sheet. $AIKI— Tommy Coops (@ohheytommy) October 12, 2021
      👍️0
      georgie18 georgie18 3 years ago
      AIKI...92...on the P/M Gappa...:partying_face:
      👍️0
      urge2surge urge2surge 3 years ago
      Impressed with the CEO management taking investment stakes in pivotal companies, thereby adding significant value here. Great job IMO.
      👍️0
      TGOO TGOO 3 years ago
      Interesting, low ss here...
      👍️0
      Sirpeter Sirpeter 3 years ago
      Very volatile but looks ready
      👍️0
      sportd sportd 3 years ago
      Added let’s see what this can do
      👍️0
      Sirpeter Sirpeter 3 years ago
      Kaboom!
      👍️0
      Sirpeter Sirpeter 3 years ago
      Bullish
      👍️0
      antman antman 3 years ago
      Would be nice... it has been ages since they did the financing around $1.65 and it began to drop ever since
      👍️0
      db101 db101 3 years ago
      AIkido Pharma Releases Shareholder Update; Near Term Catalysts Approaching
      👍️0
      db101 db101 3 years ago
      News...
      👍️0
      georgie18 georgie18 3 years ago
      AIKI...86...Tue, July 27, 2021, 10:00 AM
      AIkido's License to Technology Includes Targeted Psilocybin Treatment for Cancer Patients

      NEW YORK, July 27, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for application No.: 16/477,125. This technology relates to the use of novel and proprietary central nervous system (CNS) homing peptides. This technology has been exclusively sublicensed to AIkido Pharma for use of psilocybin for the therapeutic treatment of neuroinflammatory disease in cancer patients.
      👍️0
      georgie18 georgie18 3 years ago
      AIKI...97...Bounce off the .85 range on the Bullish Engulfing Reversal Candle to the Upside...

      Psar flipped to a Bullish Buy Position...as the MACD Crossed to the positive side...

      Chart...https://schrts.co/FqVVQIHY ...
      👍️0
      wesley_ wesley_ 3 years ago
      $1.10 nice
      👍️0
      urge2surge urge2surge 3 years ago
      No respect from the street on this company. Corporate..how about getting some dignity and respect by actually executing and aggressive communications to the investing arena? Grow a pair..
      👍️0
      urge2surge urge2surge 3 years ago
      Yeah definitely under substantial book value here. Not just on cash, but potential pipeline, nols, licensing rev's. You buy the dips here and wait on a significant return.
      👍️0
      Chess Master Chess Master 3 years ago
      BULLISH RESEARCH ARTICLE! Trading under cash and great upside on great results. https://insiderfinancial.com/akido-pharmas-aiki-clinical-trial-results-continues-to-validates-gileads-21-billion-purchase-of-immunomedics/181580/
      👍️0
      ClayTrader ClayTrader 3 years ago
      * * $AIKI Video Chart 04-21-2021 * *

      Link to Video - click here to watch the technical chart video

      👍️0
      georgie18 georgie18 3 years ago
      AIKI...86...NEW YORK, April 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today noted that a recent study announced positive early results from a PSMA 617-Lu177 study conducted by a leading global pharmaceutical company. The report provides strong indications for analogous success in similar technology the Company is helping to develop.

      The article can be accessed at:
      https://www.thepharmaletter.com/article/further-vindication-for-novartis-in-radioligand-space
      👍️0
      georgie18 georgie18 3 years ago
      AIKI...$1.20...in the P/M...NEW YORK, April 7, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has been granted an exclusive sublicense to technology related to the use of novel and proprietary central nervous system (CNS) homing peptides for the therapeutic treatment of neuroinflammatory disease in cancer patients...

      https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1857821
      👍️0
      georgie18 georgie18 3 years ago
      AIKI...$1.17...Bidding the Lower Band to the 20ma to add to my Core Position...

      Looking for the 2 Open Gaps to fill and a $2 Breakout..imo...we shall see....

      Chart...https://schrts.co/BrjKBXYy ...
      👍️0
      georgie18 georgie18 3 years ago
      AIKI...$1.17...in the P/M...https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1849940 ...:party:
      👍️0
      Taurus69 Taurus69 3 years ago
      $aiki $1.17 ? 0.0 (0.00%)
      Volume: 3,920,435 @03/26/21 7:41:58 PM EDT
      👍️0
      ClayTrader ClayTrader 4 years ago
      * * $AIKI Video Chart 03-24-2021 * *

      Link to Video - click here to watch the technical chart video

      👍️0

      Your Recent History

      NASDAQ
      AIKI
      Alkido Pharma
      Delayed Upgrade Clock